Bourgeon Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,200	Closed	-$154K	–	325
2020 Q2	$154K	Buy	9,200 +1,000	+12%	+$16.7K	0.05%	82
2020 Q1	$118K	Buy	+8,200	New	+$118K	0.06%	78
2018 Q2	–	Sell	-6,500	Closed	-$207K	–	81
2018 Q1	$207K	Buy	+6,500	New	+$207K	0.11%	69